6 Feb 2019 5th Nordic Pathology Meeting – Sweden 2019 by Monica Sandström | posted in: Uncategorized | 0 5th Nordic Pathology Meeting - Sweden 2019 Försök att betygsätta följande påståenden om/inslag i kursen på en skala 1-5 med 1 som sämst och 5 som bäst.KursnamnHow good has the meeting fulfilled your expectations?12345No opinionHow much has the meeting contributed to giving you new knowledge of the subject?12345No opinionHow well did Clarion Hotel Arlanda work as a meeting venue?12345No opinionWhat overall rating would you put on themeeting?12345No opinionPD-L1 as a biomarker for IO in NSCLC (K Kerr)12345No opinionPD-L1 on cytology (B Guldhammer Skov)12345No opinionPD-L1 - NordiQC experiences (M Vyberg)12345No opinionDiscussions of the morning sessions (B Guldhammer Skov)12345No opinionOther biomarker for IO, including TMB (K Kerr)12345No opinionPD-L1 prevalence in an unselected (Danish) population (B Guldhammer Skov)12345No opinionClinical aspects of fusion genes in NSCLC (J Koivunen)12345No opinionMolecular analyses of fusion genes (F Enlund)12345No opinionQuestions and answers12345No opinionTargets beyond EGFR and ALK in NSCLC (S Ekman)12345No opinionWhat to report and not to report in the molecular pathology report (J Botling)12345No opinionWrap-up12345No opinionAn update on the use of EGFR TKIs in NSCLC (O Terje Brustugun, )12345No opinionLiquid biopsies in EGFR-mutation positive patients – when to use it and which methods (J Kononen)12345No opinionRebiopsy in EGFR TKI treated patients – when and how? (J Kononen)12345No opinionBreakout sessions countrywise12345No opinionStatus on IO in MPM and SCLC (Clinical) (J Benn Sørensen)12345No opinionDelta-like protein 3 (DLL3) ADC in SCLC - (Rova-T) (S Langer)12345No opinionMPM prognostic markers and potential therapeutic targets (O Dimitri Røe)12345No opinionSubtyping of Malignant Mesothelioma including reproducibility of biphasic mesothelioma: Data from the MESOPATH reference center (F Galateau-Sallé)12345No opinionGenomic Medicin Sweden (GMS) and its implication on biomarker analysis in lung cancer (R Rosenquist Brandell)12345No opinionDiscussion and Close up! (Organizing Committee)12345No opinionOther comments on the meeting
